Acorah Software Products - Accounts Production 15.0.600 false true 30 April 2023 28 April 2022 false 1 May 2023 30 April 2024 30 April 2024 14076834 Dr Jeremy Boyle iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14076834 2023-04-30 14076834 2024-04-30 14076834 2023-05-01 2024-04-30 14076834 frs-core:CurrentFinancialInstruments 2024-04-30 14076834 frs-core:CopyrightsPatentsTrademarksServiceOperatingRights 2024-04-30 14076834 frs-core:CopyrightsPatentsTrademarksServiceOperatingRights 2023-05-01 2024-04-30 14076834 frs-core:CopyrightsPatentsTrademarksServiceOperatingRights 2023-04-30 14076834 frs-core:InvestmentPropertyIncludedWithinPPE 2023-05-01 2024-04-30 14076834 frs-core:SharePremium 2024-04-30 14076834 frs-core:ShareCapital 2024-04-30 14076834 frs-core:RetainedEarningsAccumulatedLosses 2024-04-30 14076834 frs-bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 14076834 frs-bus:FilletedAccounts 2023-05-01 2024-04-30 14076834 frs-bus:SmallEntities 2023-05-01 2024-04-30 14076834 frs-bus:AuditExempt-NoAccountantsReport 2023-05-01 2024-04-30 14076834 frs-bus:SmallCompaniesRegimeForAccounts 2023-05-01 2024-04-30 14076834 frs-bus:Director1 2023-05-01 2024-04-30 14076834 frs-countries:EnglandWales 2023-05-01 2024-04-30 14076834 2022-04-27 14076834 2023-04-30 14076834 2022-04-28 2023-04-30 14076834 frs-core:CurrentFinancialInstruments 2023-04-30 14076834 frs-core:SharePremium 2023-04-30 14076834 frs-core:ShareCapital 2023-04-30 14076834 frs-core:RetainedEarningsAccumulatedLosses 2023-04-30
Registered number: 14076834
Beynon Boyle Medical Ltd
Unaudited Financial Statements
For The Year Ended 30 April 2024
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3
Page 1
Balance Sheet
Registered number: 14076834
2024 2023
Notes £ £ £ £
FIXED ASSETS
Intangible Assets 4 57,227 41,672
57,227 41,672
CURRENT ASSETS
Cash at bank and in hand 7,582 26,533
7,582 26,533
Creditors: Amounts Falling Due Within One Year 5 (2,160 ) (1,081 )
NET CURRENT ASSETS (LIABILITIES) 5,422 25,452
TOTAL ASSETS LESS CURRENT LIABILITIES 62,649 67,124
NET ASSETS 62,649 67,124
CAPITAL AND RESERVES
Called up share capital 6 1 1
Share premium account 70,999 70,999
Profit and Loss Account (8,351 ) (3,876 )
SHAREHOLDERS' FUNDS 62,649 67,124
Page 1
Page 2
For the year ending 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Dr Jeremy Boyle
Director
30/01/2025
The notes on page 3 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Beynon Boyle Medical Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14076834 . The registered office is Epic House, 128 Fulwell Road, Teddington, Middlesex, TW11 0RQ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Intangible Fixed Assets and Amortisation - Intellectual Property
Intellectual property assets are patent and legal costs. It is amortised to the profit and loss account over its estimated economic life of 20 years.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 1)
1 1
4. Intangible Assets
Intellectual Property
£
Cost
As at 1 May 2023 43,865
Additions 18,683
As at 30 April 2024 62,548
Amortisation
As at 1 May 2023 2,193
Provided during the period 3,128
As at 30 April 2024 5,321
Net Book Value
As at 30 April 2024 57,227
As at 1 May 2023 41,672
5. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Trade creditors - 1
Accruals 2,160 1,080
2,160 1,081
6. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 1 1
Page 3